Cite
Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer.
MLA
Ren, Shancheng, et al. “Long Non-Coding RNA Metastasis Associated in Lung Adenocarcinoma Transcript 1 Derived MiniRNA as a Novel Plasma-Based Biomarker for Diagnosing Prostate Cancer.” European Journal of Cancer, vol. 49, no. 13, Sept. 2013, pp. 2949–59. EBSCOhost, https://doi.org/10.1016/j.ejca.2013.04.026.
APA
Ren, S., Wang, F., Shen, J., Sun, Y., Xu, W., Lu, J., Wei, M., Xu, C., Wu, C., Zhang, Z., Gao, X., Liu, Z., Hou, J., Huang, J., & Sun, Y. (2013). Long non-coding RNA metastasis associated in lung adenocarcinoma transcript 1 derived miniRNA as a novel plasma-based biomarker for diagnosing prostate cancer. European Journal of Cancer, 49(13), 2949–2959. https://doi.org/10.1016/j.ejca.2013.04.026
Chicago
Ren, Shancheng, Fubo Wang, Jian Shen, Yi Sun, Weidong Xu, Ji Lu, Min Wei, et al. 2013. “Long Non-Coding RNA Metastasis Associated in Lung Adenocarcinoma Transcript 1 Derived MiniRNA as a Novel Plasma-Based Biomarker for Diagnosing Prostate Cancer.” European Journal of Cancer 49 (13): 2949–59. doi:10.1016/j.ejca.2013.04.026.